REGENERON PHARMACEUTICALS
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for REGENERON PHARMACEUTICALS OPTION, CUSIP 75886F958.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for REGENERON PHARMACEUTICALS OPTION, CUSIP 75886F958.